NYSE:PRGOPerrigo Stock Price, Forecast & News

$56.38

+0.94 (+1.70 %)

(As of 06/2/2020 04:00 PM ET)

Add

Compare

Today's Range

$54.42

Now: $56.38▼

$56.48

50-Day Range

$49.62

MA: $52.86▼

$55.53

52-Week Range

$40.01

Now: $56.38▼

$63.86

Volume710,093 shs

Average Volume1.22 million shs

Market Capitalization$7.69 billion

P/E Ratio41.15

Dividend Yield1.62%

Beta1.2

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, minerals and dietary supplements, feminine hygiene, diabetes care, scar management, and anti-parasite categories under the Good Sense, Sergeant's, Sentry, Zephrex D, PetArmor, and ScarAway brand names. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force. It operates in Europe, Australia, Israel, Mexico, the United States, Canada, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Beat the Market (BTM) Rank^™

2.3 Analyst's Opinion

Consensus Rating
Perrigo has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 4 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $56.86, Perrigo has a potential upside of 0.8% from its current price of $56.38.
Amount of Analyst Coverage
Perrigo has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.5 Community Rank

Outperform Votes
Perrigo has received 735 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Perrigo has received 717 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Perrigo has received 50.62% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Perrigo and other stocks. Vote “Outperform” if you believe PRGO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PRGO will underperform the S&P 500 over the long term. You may vote once every thirty days.

5.0 Dividend Strength

Dividend Leadership
Perrigo is a leading dividend payer. It pays a dividend yield of 1.62%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Perrigo has been increasing its dividend for 17 years.
Dividend Coverage
The dividend payout ratio of Perrigo is 22.33 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Perrigo will have a dividend payout ratio of 20.59 % next year. This indicates that Perrigo will be able to sustain or increase its dividend.

4.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Perrigo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $85,000.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 0.30% of the stock of Perrigo is held by insiders.
Percentage Held by Institutions
83.90% of the stock of Perrigo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Perrigo are expected to grow by 7.90% in the coming year, from $4.05 to $4.37 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Perrigo is 41.15, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.86.
Price to Earnings Ratio vs. Sector
The P/E ratio of Perrigo is 41.15, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 18.90.
Price to Earnings Growth Ratio
Perrigo has a PEG Ratio of 13.54. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Perrigo has a P/B Ratio of 1.32. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.88 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Pharmaceutical preparations

Sub-IndustryPharmaceuticals

SectorMedical

Current SymbolNYSE:PRGO

Previous Symbol

CUSIP71429010

CIK1585364

Webwww.perrigo.com

Phone353-1709-4000

Debt

Debt-to-Equity Ratio0.55

Current Ratio1.86

Quick Ratio1.29

Price-To-Earnings

Trailing P/E Ratio41.15

Forward P/E Ratio13.92

P/E Growth13.54

Sales & Book Value

Annual Sales$4.84 billion

Price / Sales1.59

Cash Flow$7.12 per share

Price / Cash Flow7.92

Book Value$42.64 per share

Price / Book1.32

Profitability

EPS (Most Recent Fiscal Year)$4.03

Net Income$146.10 million

Net Margins3.77%

Return on Equity9.72%

Return on Assets4.93%

Miscellaneous

Employees11,200

Outstanding Shares136,313,000

Market Cap$7.69 billion

Next Earnings Date8/13/2020 (Estimated)

OptionableOptionable

Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter.

Perrigo (NYSE:PRGO) Frequently Asked Questions

How has Perrigo's stock been impacted by COVID-19 (Coronavirus)?

Perrigo's stock was trading at $46.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PRGO shares have increased by 22.5% and is now trading at $56.38. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Perrigo?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Perrigo.

When is Perrigo's next earnings date?

Perrigo is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Perrigo.

How were Perrigo's earnings last quarter?

Perrigo Company PLC (NYSE:PRGO) posted its quarterly earnings data on Thursday, April, 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.09 by $0.05. The company earned $1.34 billion during the quarter, compared to the consensus estimate of $1.33 billion. Perrigo had a return on equity of 9.72% and a net margin of 3.77%. Perrigo's revenue for the quarter was up 14.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.07 EPS. View Perrigo's earnings history.

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo declared a quarterly dividend on Tuesday, May 5th. Investors of record on Friday, May 29th will be given a dividend of $0.225 per share on Tuesday, June 16th. This represents a $0.90 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date is Thursday, May 28th. View Perrigo's dividend history.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo issued an update on its first quarter 2020 After-Hours earnings guidance on Tuesday, April, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.3-1.3 billion, compared to the consensus revenue estimate of $1.26 billion.

What price target have analysts set for PRGO?

8 equities research analysts have issued 12 month target prices for Perrigo's stock. Their forecasts range from $52.00 to $70.00. On average, they expect Perrigo's share price to reach $56.86 in the next twelve months. This suggests a possible upside of 0.8% from the stock's current price. View analysts' price targets for Perrigo.

Has Perrigo been receiving favorable news coverage?

News coverage about PRGO stock has trended very negative this week, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Perrigo earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutPerrigo.

Who are some of Perrigo's key competitors?

Some companies that are related to Perrigo include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), AbbVie (ABBV), Zoetis (ZTS), Allergan (AGN), Horizon Therapeutics (HZNP), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX), Corcept Therapeutics (CORT) and Zogenix (ZGNX). View all competitors.

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Netflix (NFLX), Allergan (AGN), Johnson & Johnson (JNJ), Celgene (CELG), Intel (INTC) and QUALCOMM (QCOM).

Who are Perrigo's key executives?

Perrigo's management team includes the following people:

Mr. Murray S. Kessler, CEO, Pres & Director (Age 59)
Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 59)
Mr. Jeffrey R. Needham, Exec. VP & Pres of Consumer Healthcare Americas (Age 63)
Mr. Svend Andersen, Exec. VP & Pres of Consumer Healthcare International (Age 57)
Mr. Ronald L. Winowiecki, Advisory (Age 53)

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Who are Perrigo's major shareholders?

Perrigo's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.20%), State Street Corp (4.53%), Franklin Resources Inc. (3.31%), Sound Shore Management Inc. CT (1.82%), Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management (1.70%) and London Co. of Virginia (1.67%). Company insiders that own Perrigo stock include Geoffrey M Parker, Grainne Quinn, Murray S Kessler, Ronald Craig Janish, Ronald Winowiecki, Svend Andersen, Theodore R Samuels II and Todd W Kingma. View institutional ownership trends for Perrigo.

Which major investors are selling Perrigo stock?

PRGO stock was sold by a variety of institutional investors in the last quarter, including Parnassus Investments CA, Franklin Resources Inc., Invesco Ltd., Sound Shore Management Inc. CT, Two Sigma Advisers LP, Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management, AXA, and Harel Insurance Investments & Financial Services Ltd.. Company insiders that have sold Perrigo company stock in the last year include Grainne Quinn, Ronald Craig Janish, Ronald Winowiecki, and Todd W Kingma. View insider buying and selling activity for Perrigo.

Which major investors are buying Perrigo stock?

PRGO stock was acquired by a variety of institutional investors in the last quarter, including London Co. of Virginia, Nuveen Asset Management LLC, Alyeska Investment Group L.P., First Trust Advisors LP, Balyasny Asset Management LLC, Alliancebernstein L.P., Camber Capital Management LP, and Meitav Dash Investments Ltd.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Murray S Kessler, Svend Andersen, Theodore R Samuels II, and Todd W Kingma. View insider buying and selling activity for Perrigo.

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $56.38.

How big of a company is Perrigo?

Perrigo has a market capitalization of $7.69 billion and generates $4.84 billion in revenue each year. The company earns $146.10 million in net income (profit) each year or $4.03 on an earnings per share basis. Perrigo employs 11,200 workers across the globe.

What is Perrigo's official website?

The official website for Perrigo is www.perrigo.com.

How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]

This page was last updated on 6/3/2020 by MarketBeat.com Staff